A woman who has relied on plasma-derived medicines for 22 years has met local plasma donors to thank them and share how ...

A woman is battling her insurance company, Blue Cross Blue Shield of Oklahoma, after she received multiple denials for life-saving medicine.

Campfire Circle delivers camp-inspired programs to pediatric hospitals across Ontario, including London Health Sciences ...

Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...

PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures in its captable, has raised capital from ...

Morris & Dickson, the nation’s largest independent wholesale and specialty distributor, today announced that it has signed a non-binding Letter of Intent (LOI) to acquire Prodigy Health, a privately ...

SHREVEPORT, La., December 08, 2025--(BUSINESS WIRE)--Morris & Dickson, the nation’s largest independent wholesale and specialty distributor, today announced that it has signed a non-binding Letter of ...

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the first in Arizona treated with a new immune cell therapy known as TECELRA at ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, ...